Amgen

AMGN

HealthcareNMS$190.8B

AMGN SEC filings last scanned 22 Aug 2026, 16:40 UTC

CEO Timeline

Robert A. BradwayCurrent

May 2012 — Present(14y 4mo)

Robert A. Bradway was appointed Chief Executive Officer of Amgen Inc., effective May 23, 2012, succeeding Kevin W. Sharer.

2 source filings — click to expand

Kevin W. Sharer

Since at least Mar 2005 — May 2012(7y 2mo)

planned retirement

2 source filings — click to expand